Tagged with Exclusiv

Pharma Francesco di Marco, General Manager for Amgen Italy, shares his view on the state of the Italian pharmaceutical sector, the turnaround the company has made in the country, and what he sees as the keys to unlocking Italy’s potential for innovation over the next few years. Having worked for Amgen…

Pharma Galderma Italy was a founding European affiliate for the company and has seen incredible growth in the past two decades. Managing Director  Bernat Albinyana discusses the affiliate’s performance, its business organization and commitment to R&D, as well as its grand ambitions for the next few years. In 1986, Italy was…

Pharma Tabuk Pharmaceuticals, the largest private Saudi pharmaceutical company with commercial operations in 25 countries in middle east and 5 European countries with a portfolio of more than 250 products, chose Egypt to consolidate its international presence in the Middle East and North Africa. The general manager for Egypt and Sudan…

Pharma Paul Korte, General Manager for Janssen in the Netherlands, highlights the strategic move and leadership position taken up by Janssen in the oncology field, and calls on Dutch healthcare stakeholders to adopt the positive and collaborative attitude that will ensure Dutch patients can still expect to access the most innovative…

Pharma Dr. Ermano Buratti, General Manager for Astellas Pharma in Italy, discusses the company’s evolution as it enters its second decade, the importance of partnering with the government on reimbursement, the current state and need for change in the country’s healthcare system, and his efforts to put Astellas in a position…

Pharma In an exclusive interview, the Vice President of Philips Research explains the key to continuous evolution, improving healthcare stakeholder relations, and fostering “Open Innovation.” You have been Vice President of Philips Research since 2007, a centenarian institution that stands as one of the largest private research organizations in the world.…

Pharma Healthcare is moving towards an increased level of personalization and active participation of the patient in the decision-making process. Roland van Esch, General Manager of Zimmer Biomet Netherlands, shares his perspective on how patient and hospital management will evolve in the future. In April 2014 Zimmer announced the acquisition of…

Pharma Teva Benelux and Nordics’ GM lifts the lid on how the company has grown to become the market leader in the Netherlands. Looking at Teva’s activities, your market leader position in the Netherlands and your global ambitions, a truly ambitious culture emanates from TEVA’s achievements. Where does this drive come from?…

Pharma Takeda’s goal is to become a trusted and reliable partner in the healthcare system by better understanding patients’ needs. Aarnoud Overkamp, general manager of the Dutch subsidiary, shares his perspective on the challenges faced by the local healthcare system, the importance of Takeda-ism in the organization, and finding innovative ways…

Pharma In 2008 Focus Reports interviewed Mr. Federico Seghi Recli as he prepared to transform Molteni Farmaceutici into an International specialty pharma company. Today we catch up on the progress, investments and strategic decisions which have been made since, and ask how he plans to continue his remarkable growth as well…

Pharma Hersol prides itself on producing high-quality products and is today one of the leading Pharmaceutical Contract Manufacturing Companies (CMOs) within the South African Market. The managing director discusses the development of the company, its current challenges as well as its future ambitions. Can you please provide our readers with some…

Pharma Albert Denoon (AB) and Jeff Hampton (JH) illustrate how the Crossroads and Campbell Institutes, two non-profit organizations funded by Baroque Medical, are well positioned to address South Africa’s current gaps in medical training. They also depict the key success factors that have allowed the company to become the leading distributor…